Neurobo Pharmaceuticals Inc NRBO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:42 PM EDT
3.10quote price arrow up+0.01 (+0.32%)
Volume
145,747
52 week range
2.70 - 7.61

...

Loading . . .
  • Open3.15
  • Day High3.15
  • Day Low2.97
  • Prev Close3.09
  • 52 Week High7.61
  • 52 Week High Date01/06/21
  • 52 Week Low2.70
  • 52 Week Low Date07/19/21

Key Stats

  • Market Cap69.10M
  • Shares Out22.29M
  • 10 Day Average Volume13.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-41.71

KEY STATS

  • Open3.15
  • Day High3.15
  • Day Low2.97
  • Prev Close3.09
  • 52 Week High7.61
  • 52 Week High Date01/06/21
  • 52 Week Low2.70
  • 52 Week Low Date07/19/21
  • Market Cap69.10M
  • Shares Out22.29M
  • 10 Day Average Volume13.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-41.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.67
  • P/E (TTM)-1.86
  • Fwd P/E (NTM)-4.77
  • EBITDA (MRQ)-10.91M
  • ROE (MRQ)-270.66%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neurobo Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
NeuroBo Pharmaceuticals, Inc., formerly Gemphire Therapeutics Inc., is a clinical-stage biotechnology company. The Company is focused on developing pharmaceuticals to treat neurodegenerative disorders. The Company is addressing unmet needs in patients with Painful Diabetic Neuropathy (PDN) and Alzheimer’s disease. The Company’s product candidate, NB-01, is targeting neuropathic pain with an indication in PDN. The Company also provides NB-02, which is an Alzheimer’s and...
Douglas Swirsky CPA
Chairman
jeong Gu Kang Ph.D.
President
Akash Bakshi
Chief Operating Officer
Address
200 BERKELEY ST., FL 19
Boston, MA
02116
United States

Top Peers

SYMBOLLASTCHG%CHG
MNPR
Monopar Therapeutics Inc
5.50+0.40+7.92%
DARE
Dare Bioscience Inc
1.59+0.07+4.28%
SYN
Synthetic Biologics Inc
0.5293-0.0237-4.2767%
GLMD
Galmed Pharmaceuticals Ltd
2.45-0.06-2.39%
LUMO
Lumos Pharma Inc
7.58+0.22+2.99%